The use of rituximab, abatacept and Janus kinase inhibitors (JAKis) in individuals with rheumatoid arthritis (RA) was ...

A logical first approach might be to target appropriate members of the Janus kinase (JAK) family or the signal transducers and activators of transcription (STAT) family, as these proteins are ...

Deuruxolitinib showed significant efficacy and safety in hair regrowth stimulation among adult patients with alopecia areata, ...

DelveInsight’s, “Janus Kinase Inhibitor Pipeline Insight 2024” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Janus Kinase (JAK) Inhibitor pipeline ...

Discover a study that demonstrated that baricitinib significantly improved clinical signs of moderate-to-severe paediatric ...

Patients with IBD don’t face an increased risk for major adverse cardiovascular events when taking Janus kinase inhibitors ...

The following is a summary of “Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic ...

The controversy erupted on June 26, 2024, when Elanco revealed that Zenrelia's label would include a boxed warning, highlighting safety issues identified during trials with unvaccinated dogs. The ...

Growing awareness of axial spondyloarthritis among the public is a key driver. Government-led initiatives, healthcare camps, and a focus on disease prevention contribute to heightened awareness, ...